Ursula Fritsch

Ursula Fritsch is the Chief Regulatory Officer at KaliVir Immunotherapeutics, bringing over 30 years of experience in the biotechnology and pharmaceutical industry. She has extensive experience in overseeing global regulatory affairs for various therapeutics across the development lifecycle, including pre-IND, IND, BLA/NDA, Advisory Committee, post-marketing, and commercial stages. Dr. Fritsch has successfully conducted regulatory and inspection negotiations with authorities in numerous countries, with 15 years of experience specifically with oncolytic viruses.